Bioamber Inc. (BIOA) Files Form 4 Insider Buying : Michael A. Hartmann Buys 3,000 Shares

Bioamber Inc. (BIOA): Michael A. Hartmann , Executive Vice President of Bioamber Inc. purchased 3,000 shares on May 5, 2016. The Insider buying transaction was reported by the company on May 9, 2016 to the Securities and Exchange Commission. The shares were purchased at $3.42 per share for a total value of $10,315.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Dec 4, 2015, Michael A. Hartmann (Executive Vice President) sold 21,477 shares at $8.11 per share price.On Dec 4, 2015, Jean-francois Huc (President and CEO) sold 27,278 shares at $8.11 per share price.Also, On Sep 1, 2015, Andrew P. Ashworth (CFO) purchased 700 shares at $6.01 per share price.On Aug 13, 2015, Kenneth W. Wall (director) purchased 10,000 shares at $6.05 per share price.

Shares of Bioamber Inc (BIOA) ended Friday, May 6, 2016 session in red amid volatile trading. The shares closed down -0.35 points or -10.20% at $3.08 with 1,00,348 shares getting traded. Post opening the session at $3.45, the shares hit an intraday low of $2.98 and an intraday high of $3.47 and the price vacillated in this range throughout the day. The company has a market cap of $89 M and the number of outstanding shares has been calculated to be 2,87,81,753 shares. The 52-week high of Bioamber Inc is $9.09 and the 52-week low is $2.865.

Bioamber Inc Money Flow Index Chart

BioAmber Inc. (BioAmber) is an industrial biotechnology company which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals which are used in a wide range of everyday products including plastics resins food additives and personal care products. The Company is developing three distinct technologies such as the production of succinic acid through fermentation; the conversion of succinic acid into 14 BDO THF and GBL by catalyst assisted hydrogenation reaction and the production of adipic acid and other C6 chemical intermediates through fermentation and purification with or without catalytic conversion. BioAmber manufactures and sells bio-succinic acid to the customers in a range of chemical markets. It produces bio-succinic acid in a facility using a 350000 liter fermenter in Pomacle France.

Leave a Reply

Bioamber Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Bioamber Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.